Feng Dai

Impact of local tumor lesion treatments and preoperative indicators on the survival of patients with small hepatocellular carcinomas

W. Ye, Yongxiang Yi, Yanyan Wei, 2018, Oncology Letters.

Radiofrequency ablation or microwave ablation combined with transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma by comparing with radiofrequency ablation alone.

Yongxiang Yi, Feng Dai, Guilan Lu, 2014, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Transcatheter arterial chemoembolization monotherapy vs combined transcatheter arterial chemoembolization–percutaneous microwave coagulation therapy for massive hepatocellular carcinoma (≥10 cm)

W. Ye, Yanyan Wei, Feng Dai, 2018, Cancer Management and Research.

Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.

D. Goldberg, T. Taddei, R. Fox, 2017, Gastroenterology.

Low expression of trafficking protein particle complex 4 predicts poor prognosis in hepatocellular carcinoma.

Jue Wei, C. Gu, Z. Bian, 2018, International journal of clinical and experimental pathology.

Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States

T. Taddei, R. Fox, M. Skanderson, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database.

M. Pedrosa, M. Duggal, T. Taddei, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Recalibrating the Child–Turcotte–Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis

M. Pedrosa, T. Taddei, R. Fox, 2016, Digestive Diseases and Sciences.

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

H Zhao, C. Zheng, Q. Tu, 2023, Signal Transduction and Targeted Therapy.

High expression of ubiquitin-conjugating enzyme E2A predicts poor prognosis in hepatocellular carcinoma.

J. Shao, Z. Bian, H. Ji, 2018, Oncology letters.